Literature DB >> 6198377

Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens.

S L Swain, D P Dialynas, F W Fitch, M English.   

Abstract

The ability of antibody to Lyt-2 and to the newly described L3T4 antigen to block the functions of helper T cells with specificity for allogeneic class 1 or class 2 MHC subregion antigens was determined. Anti-Lyt-2 blocked both allohelp delivered by unprimed T cells and IL 2 production by primed T cells when the response was directed to class 1 MHC antigens, but had no effect when the response was directed to class 2 MHC or Mls antigens. Anti-L3T4 had reciprocal activity. A control reagent, anti-LFA-1, blocked all responses tested regardless of specificity. This and other reports provide strong evidence that L3T4 is the murine equivalent of the human T cell markers Leu 3/OKT4. The ability of antibodies directed against Lyt-2 and L3T4 to block T cell function in a fashion determined by the class of MHC antigen recognized by the T cell further supports the hypotheses that Lyt-2 and L3T4 molecule in the mouse and Leu-2 and Leu-3 molecules in the human are involved in the interaction of the T cell with class-specific determinants on MHC molecules.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198377

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

Review 2.  Current and future therapies for myasthenia gravis.

Authors:  Q Yi; A K Lefvert
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 3.  Antigen presenting cells.

Authors:  D L Hamilos
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

4.  Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells.

Authors:  J P Zou; J Shimizu; K Ikegame; H Takiuchi; H Fujiwara; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Analysis of the function of L3T4+ T cells by in vivo treatment with monoclonal antibody to L3T4.

Authors:  D Wofsy; W E Seaman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

6.  Expression of L3T4 molecules on Lyt-2+, class II-restricted antigen-specific T suppressor lymphocytes.

Authors:  J Heuer; J Degwert; E Kölsch
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 7.  T-cell clones and T-cell receptors.

Authors:  F W Fitch
Journal:  Microbiol Rev       Date:  1986-03

8.  Tumor infiltrating lymphocytes of spontaneous versus transplanted mouse mammary tumors.

Authors:  W Z Wei; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

9.  Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.

Authors:  L C Lim; D M England; N J Glowacki; B K DuChateau; R F Schell
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  In vivo inhibition by a monoclonal antibody to CD4+ T cells of humoral and cellular immunity in sheep.

Authors:  H S Gill; D L Watson; M R Brandon
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.